Jagx stock forecast 2021. 69%) At close: Jan 17, 2025, 4:00 PM.

Jagx stock forecast 2021 Home; Getting Started. Skip to main content. 02. FAQ. Jaguar Health Inc. View Jaguar Health, Inc. The following data is used in our analysis model to generate this report. NASDAQ: JAGX · Real-Time Price · USD. Price $0. 14%. 845000028610229. Find the latest Jaguar Health, Inc. 1 million. 98M. 03, revenue of $2. 89M. Jaguar Animal Health Inc Stock Price Forecast, "JAGX" Predictons for2025 JAGX: JAGUAR HEALTH INC. JAGX earnings call for the period ending March 31, 2021. Insiders Ownership 12. With the completion of the PIPE financing of unregistered shares and 6-month lock up term, Jaguar has agreed, as described below, not to issue additional equity securities before October 22, 2023 - by which point the Company expects to have released top Jaguar family company Napo Therapeutics is an Italian corporation Jaguar established in Milan, Italy in 2021 focused on expanding crofelemer access in Europe and specifically for orphan and/or rare diseases. TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 ; Period Ending. Karen Brunke, EVP di Jaguar e CEO ad interim di Magdalena, fornirà una panoramica dei progressi della compagnia nello sviluppo di nuovi farmaci naturali prescrivibili per indicazioni relative alla salute mentale. View daily, weekly or monthly format back to when Jaguar Health, Inc. login register. com. JAGX Stock Data Market Cap 8. veja seus indicadores fundamentalistas, variação, MÓDULO FORECAST. Jaguar Health Inc (JAGX) Follow ST. 8% increase from 2021. 68M. (NASDAQ: JAGX) (“Jaguar” or the “Company”) today announced that the Company will effect a reverse stock split of its issued and outstanding voting common stock (“Common Stock”), at an exchange ratio of 1-for-3, on Wednesday, September 8, 2021 (the “Effective Date”). 4% during Tuesday's session. All Financial information is relevant for the Year Ended 2021. 85. 006 (0. The company reported worse-than-expected second-quarter results. The study aims for full approval by collecting evidence of effectiveness. future price: according to them, JAGX price has a max estimate of 6. JAGX stock forecast. 50M. This price target corresponds to an upside of 461. Trading Info Ratios. JAGX is a company that went public in 2015 within the health care sector. 8 millones). Based on the ratings of 7, the consensus recommendation for JAGX is BUY Stock Prediction and Forecast [JAGX] price prediction was made for Friday, April 26, 2024 ️ Check the most recent JAGX analysis at: https://stockinvest. 00 for Jaguar Animal Health, Inc. 6%. 00 USD and a min estimate of 6. JAGX Stock Data Market Cap 13. Over the past 52 weeks, JAGX's average broker recommendation rating improved by 0. 00: i. historical stock charts and prices, analyst ratings, financials, and today’s real-time JAGX stock price. 7. 2 million, although improved from $12. *example for US securities, for non-US equivalent regulatory forms and See more Find the latest Jaguar Health Inc (JAGX) stock forecast, 12-month price target, predictions and analyst recommendations. This page (NASDAQ:JAGX) was last updated on 1/17/2025 by MarketBeat. UU. C) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments Ladenburg Thalmann is hosting a Scientific Showcase webinar on December 18, 2024, focusing on Jaguar Health's (NASDAQ:JAGX) clinical development of crofelemer, their plant-based anti-diarrheal drug. 24M. As of December 15th, investors have sold 677,100 shares of JAGX short. (JAGX) stock, including valuation metrics, financial numbers, share information and more. When the symbol you want to add appears, add it to My Quotes by selecting it and pressing Enter/Return. Los inversores podrán acceder a la Jaguar Health (NASDAQ:JAGX) ha annunciato un prossimo webcast per gli investitori previsto per mercoledì 13 novembre 2024, alle 8:30 ora orientale. stock downgraded to Strong Sell Candidate(Updated on Nov 12, 2021)The Jaguar Health, Inc. stock Jaguar Health, Inc. 00 USD. This is actually derived from Mytesi and is being studied for symptomatic relief of diarrhea from cholera and other diseases. 51%. Buy JAGX. 6666666666667 share position pre-split, became a 9. Total Subscriber Count was 1. 2 million the previous year, remains substantial. 84 - $21. Jan 17, 2025. This is a stock that has made some serious moves lately. Il webcast esaminerà i risultati finanziari del terzo trimestre 2024 dell'azienda e fornirà aggiornamenti aziendali. Jaguar Health story: Jaguar Health,Inc Stock Forecast for 2021 Bullish Signs Point to 5 per Share Marketing Sentinel and other headlines for Jaguar Health United States Sign In JAGX - Jaguar Health, Inc. 09. Earnings vs Market: JAGX is forecast. Trading Ideas; Tools. MENU. In addition, the technicals are strong on this chart. JAGX - Jaguar Health, Inc. SAN FRANCISCO, CA / ACCESSWIRE / November 8, 2023 / Jaguar Health, Inc. 06 - 6. Float 4. 67% from the last closing price of $0. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced that on February 7, 2023 the Company received formal notice from The Nasdaq Stock Market LLC ("Nasdaq") that Jaguar has regained compliance with Tudo sobre as ações Jaguar Health - Stock (Nasdaq) JAGX, cotação em dólar e reais, dividendos (Dividend Yield - DY), resultados, indicadores fundamentalistas, balanços, gráficos e muito mais. The range of stock forecasts for JAGX is 6. A) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments Jaguar family company Napo Therapeutics is an Italian corporation Jaguar established in Milan, Italy in 2021 focused on expanding crofelemer access in Europe and specifically for orphan and/or rare diseases. 12. JAGX has a higher upside potential (average analyst target price relative to current price) than 797. We use cookies to understand how you use our site and to improve your NASDAQ:JAGX has had an eventful start to 2021 as the micro-cap biotech firm has already surged by over 266% in the first week of trading. Forecast return on equity Is JAGX) Jaguar Health's current Earnings Per Share (EPS) is $16. This report details a machine learning model designed to forecast the future price movements of Jaguar Health Inc. com/andrewm10107Hello,Today I am talking about my prediction for $JAGX stock. Data is normalised which can introduce a delay from the source being available. Jaguar Animal Health Inc () Stock Market info Recommendations: Buy or sell Jaguar Animal Health stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Jaguar Animal Health share forecasts, stock quote and buy / sell signals below. Login Sign up. consenso e estimativas dos principais analistas do mercado global 2021 AH % 2020 AH Check out the Jaguar Health stock forecast and price target. JAGX : Jaguar Health stock forecast, predictions, and share price target for 2022, 2023 (1 year) to 2025 2021. 30. So what . This is the short-term play. 2021-09-10: Bronte Capital Management Pty Ltd: Jaguar Health (NASDAQ:JAGX) has reported statistically significant improvement in breast cancer patients in its Phase 3 OnTarget trial for crofelemer, a cancer supportive care drug. Italy in 2021, 02:47pm, Friday, 15'th Nov 2024. This stock is currently up more than 3% on an otherwise flat day in the markets. (JAGX) history of stock splits. 80M. Current FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014; Period Ending. This involves analyzing various factors that might influence the stock's value, such as the company's financial performance, industry trends, economic conditions, and market sentiment. 60M. (NASDAQ:JAGX) announced a 1-for-3 reverse stock split of its common stock, effective September 8, 2021. The average stock forecast for Jaguar Health Inc (JAGX) is 6. (JAGX) stock price quote with breaking news, financials, statistics, charts and more. 46% of Pharmaceutical Products stocks. Buy or Sell View. (JAGX) Established in Milan, Italy in 2021, Napo Therapeutics is focused on expanding access to crofelemer, Get Jaguar Health Inc (JAGX. Real time Jaguar Health (JAGX) stock price quote, stock graph, news & analysis. ChartMill assigns a Buy % Consensus number of 86% to JAGX. Jaguar Health 's annual revenue for 2021 was $4. JAGX updated stock price target summary. Esto marca el tercer producto recetado comercializado por Jaguar e inicia su presencia comercial en cuidados de soporte oncológico. Shares of Jaguar Health (JAGX-8. is a commercial-stage pharmaceuticals company. Get a real-time Jaguar Health, Inc. 47%. 845-0. Find real-time JAGX share price, quotes, news and analyst forecast on eToro. Canalevia-CA1, a canine-specific formulation of crofelemer derived from the Croton lechleri tree, remains the first and only FDA Why Jaguar Health (JAGX) Stock Is Down 15% Jaguar Health shares are trading lower by 15. Nov '24 Nov 22, 2024 Dec '23 Dec 31, 2023 Dec '22 Dec 31, 2022 Dec '21 Dec 31, 2021 Dec '20 Dec 31, 2020 Dec '19 Dec 31, 2019 2018 - 2014 Jaguar Animal Health Inc Stock Price Forecast, "JAGX" Predictons for2026 Detailed statistics for Jaguar Health, Inc. Get Jaguar Health Inc (JAGX. 75%. . First-quarter 2024 financial results for Jaguar Health show a 20% year-over-year revenue increase, reaching $2. 81, and a low forecast of $0. Includes date and ratio. (JAGX) announces agreement with FDA for a clinical field study of Canalevia-CA1, a prescription drug for chemotherapy-induced diarrhea (CID) in dogs. 69M. According to 8 stock analysts the average 12-month stock price forecast for JAGX stock is 408 which predicts an increase of 282054. 10M to $11. 52W Range. Forecasted Returns. According to present data Jaguar Animal Health's JAGX shares and potentially its market environment have Jaguar family company Napo Therapeutics is an Italian corporation Jaguar established in Milan, Italy in 2021 focused on expanding crofelemer access in Europe and specifically for orphan and/or rare diseases. 2 million, the company is transitioning to a closed specialty pharmacy network to improve patient access. Short Percent 1. 4 million from $2. Analyst Future Growth Forecasts Earnings vs Savings Rate: JAGX is forecast to remain unprofitable over the next 3 years. This was a 1 for 7 reverse split, meaning for each 7 shares of JAGX owned pre-split, the shareholder now owned 1 share. This decision follows approval from a majority of shareholders at a special meeting held in December 2020. 06 for 2025, with the lowest EPS forecast at -$2. Jaguar Health has reported its Q2 2024 financial results, highlighting a 16% increase in combined net revenue to $2. JAGX News. (JAGX) stock quote, history, news and other vital information to help you with your stock trading and investing. 02%. Float 10. Invest in Jaguar Health Create an eToro account to buy JAGX stock on a secure, user-friendly, multi-asset trading platform. 09M. Daily Signal changed days ago. 06 misses by $0. Jaguar Health Inc Stock Price Forecast, “JAGX” Predictons for2023. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced that on November 8, 2023 the Company received formal notice that the Listing Qualifications Staff (the "Staff") of The Nasdaq Stock Market LLC has granted Jaguar an additional 180-day grace period, through Consensus Price Target is the stock price analysts expect to see within a period of 0-18 months. Industry: @Pharmaceuticals Generic. Jaguar Health by TradingView. Jaguar The average one-year price target for Jaguar Health, Inc. JAGX is a nice breakout after 4 touches the trendline and trading at $1. Previously, we were Get Jaguar Health Inc (JAGX. The reverse split aims to align Jaguar's stock price with institutional investing standards, enhancing its appeal to long-term Jaguar family company Napo Therapeutics is an Italian corporation Jaguar established in Milan, Italy in 2021 focused on expanding crofelemer access in Europe and specifically for orphan and/or rare diseases. 7/7/2021: Cantor Fitzgerald: Initiated Coverage: Overweight: $900. 1-877-778-8358 Functions Templates Pricing Blog Thursday 27th October 2022 – Cambridge, UK: Leading UK video game studio Jagex, developer and publisher of the award winning RuneScape franchise, has announced its seventh successive year of growth - with revenue reaching £124. Get Free JAGX Updates. JAGX Stock Data Market Cap 12. DG) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments Find out the current price target and stock forecast for Jaguar Animal Health (JAGX) Skip to main content. 84%. is $6. The analysis focuses on breast cancer patients, who formed the majority Get Jaguar Health Inc (JAGX. 00, with a high forecast of $0. The forecasts range from a low of $6. 72, a high forecast of $0. AS OF. JAGX has a lower variance in analysts' estimates than -21% of NASDAQ:JAGX surged by 49. 26%) soared 49. The renewal extends conditional approval until December 21, 2025. 7 Days Predict. JAGX analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments View JAGX current price, quote, financial & revenue summaries, forecast, Jaguar Health Stock (NASDAQ:JAGX) Overview Revenue Ownership Financials Chart Transcripts. Check if this forecast comes true in a year, meanwhile watch Jaguar Health, Inc. Common Stock (JAGX). Jagex's Total Revenue was £124,863,000. Analyst Ratings of JAGUAR HEALTH INC(NASDAQ:JAGX) stock. 0 million in Q1 2023. The best stock market news and trading tools all in one place—your must-have platform for investing success. Short Percent 7. Jaguar Health Inc 2021-09-08: 1 - for - 3: 2019-06-07: 1 - for - 70: 2018-06-01: JAGX is currently rated as a Neutral Stock Research Expert insight you can understand; (EPS) forecast of -$0. 42M. Get a complete stock price history for Jaguar Health, starting from its first trading day. 25% on Friday to close a tremendous first week of 2021. JAGX Stock Price Prediction Model. 90 Days Predict. 8. 35M misses by $0. Try It for Just $1. Sep '24 Sep 30, 2024 Dec '23 Dec 31, 2023 Dec '22 Dec 31, 2022 Dec '21 Dec 31, 2021 Dec '20 Dec 31, 2020 Dec '19 Dec 31, 2019 2018 - 2014 05/09/2023 - 08:30 AM . Search. The drug received conditional approval in December 2021 and is the first of its kind. S&P 500 +---% | (JAGX) Q1 2021 Earnings Call Transcript. What happened. For example, a 66. Language. The developer of plant-based medicines has a promising drug pipeline. 3% on Friday, extending the pharmaceutical company's staggering gains since mid-November. 96 million, a 175. Previous Close. The average Jaguar Health stock forecast 2031 represents a -14. JAGX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks. For retail JAGX Buy or Sell today, predictions 2026, Jaguar Health price target today, Technical and Fundamental analysis. 00 by JAGX's total outstanding shares of 11,798,288. 87M. Jaguar noted a decrease in various expenses and a significant decrease in net loss attributable to shareholders by 28% from $12. Upcoming milestones include the presentation of Phase 2 HALT-D study results and the Find the latest Jaguar Health, Inc. JAGX's securities continue to be listed on Nasdaq SAN FRANCISCO, CA / ACCESSWIRE / February 8, 2023 / Jaguar Health, Inc. A Q4 2021 Earnings Release 03/24/2022 Jaguar family company Napo Therapeutics is an Italian corporation Jaguar established in Milan, Italy in 2021 focused on expanding crofelemer access in Europe and specifically for orphan and/or rare diseases. analyst estimates, including JAGX earnings per share estimates and analyst recommendations. Sequential growth of 4% from Q4 2023 indicates moderate momentum. What is Jaguar Health's current short interest? Short interest is the volume of Jaguar Health shares that have been sold short but have not yet been closed out or covered. The study analyzed data from 142 patients with solid tumors, including nearly 75 breast cancer patients receiving targeted therapies with or #JAGXSTOCK #JAGUARHEALTH #JAGX #FORECASTJaguar Health, Inc. What’s this mean for JAGX stock over the long haul? January 31, 2021 By Will Ashworth, InvestorPlace Contributor Feb 1, 2021, 5:01 am EST January 31, 2021 I Get A FREE STOCK ON ROBINHOOD! CLICK HERE: https://join. Lets take a look at their Jaguar family company Napo Therapeutics is an Italian corporation Jaguar established in Milan, Italy in 2021 focused on expanding crofelemer access in Europe and specifically for orphan and/or rare diseases. Crofelemer delayed-release tablets, under the name Canalevia ®-CA1, received conditional approval in December 2021 from the FDA for the treatment of chemotherapy-induced diarrhea JAGX Stock Data Market Cap 8. Find the latest Jaguar Health Inc. ($155,077,973). Stock - Stock Price, Institutional Ownership, Shareholders (NasdaqCM) Note: As of May 16, 2021, we no longer show owners that have not filed a 13D/G within the last year. Stock on our page and stay on top of the game. 1 million in Q2 2023 to $9. Jaguar Health 's annual revenue for 2019 was $5. 81% decrease from 2020. This has certainly been true in recent days. 00. 27M. Jaguar Health's stock price is up Jaguar family company Napo Therapeutics is an Italian corporation Jaguar established in Milan, Italy in 2021 focused on expanding crofelemer access in Europe and specifically for orphan and/or rare diseases. OQ) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments Upgrade to Premium to see how . 2021-07-07 : Cantor Fitzgerald Find the latest news for Jaguar Health, Inc. 015 (-1. Despite a decrease in gross revenue to $3. Institutions Ownership 1. Jagex made £88,940,273 from Subscriptions. JAGX. Price. stock Get Jaguar Health Inc (JAGX. JAGX Stock Data Market Cap 10. The data used in our company analysis is from S&P Global Market Intelligence LLC. u Jaguar family company Napo Therapeutics is an Italian corporation Jaguar established in Milan, Italy in 2021 focused on expanding crofelemer access in Europe and specifically for orphan and/or rare diseases. Short Percent 3. However, the ailing company has looked a little healthier at the beginning of 2021. The 11 analysts with 12-month price forecasts for Janux Therapeutics stock have an average target of 83. Jaguar Health (NASDAQ:JAGX) announced FDA approval renewal for Canalevia-CA1, their prescription drug treating chemotherapy-induced diarrhea (CID) in dogs. 39 million, a 62. See Jaguar Health, Inc. Discover historical prices for JAGX stock on Yahoo Finance. L'azienda prevede di presentare il suo Rapporto sugli Utili del Q3 2024 tramite il modulo 10-Q per il 11/08/2023 - 10:25 AM . 72 million compared to Q1 2024. 77% Magdalena Biosciences, una joint venture tra Jaguar Health e Filament Health, si appresta a presentare al BIO Investor Forum il 16 ottobre 2024. 78 million, a 30. Gelclair es un gel que se adhiere a la superficie mucosa de la boca, Get Jaguar Health Inc (JAGX. (NASDAQ:JAGX) ha anunciado su participación en la Conferencia de Inversores Lytham Partners Fall 2024, programada para el 1 de octubre de 2024. El evento virtual contará con una presentación transmitida por Lisa Conte, fundadora, presidenta y CEO de la empresa, a las 1:15 pm Eastern. Home. JAGUAR HEALTH INC's average analyst price target is greater than 250. (NASDAQ:JAGX ) Q3 2024 Results Conference Call November 12, 2024 8:30 AM ET Company Participants Lisa Conte - Founder, President Jaguar Health (NASDAQ:JAGX) ha lanzado Gelclair, un producto recetado para la mucositis oral aprobado por la FDA, en los EE. Stock | JAGX | US47010C8055 Jaguar Health (NASDAQ:JAGX) has submitted a late-breaking abstract for a first-of-kind study evaluating the impact of diarrhea from cancer therapies in breast cancer patients who received placebo in its OnTarget Phase 3 trial. 45, representing a +69,024% increase from the current price of $1. Primary endpoint based on patient reported outcomes from study expected in October 2023. The revenue also saw a 2% growth compared to Q2 2023. Watch JAGX chart and read a more detailed Jaguar Health, Inc. 86. 92M. 30 Days Predict. Stock Price Forecast. The trial evaluated crofelemer for prophylaxis of cancer therapy-related diarrhea. Jaguar Health reported a 7. Find out more. In Jaguar's case, a 1-for-60 reverse split means that every 60 shares owned will be consolidated into one share. The reverse stock split announced by Jaguar Health has several implications for investors. 5 Jaguar family company Napo Therapeutics is an Italian corporation Jaguar established in Milan, Italy in 2021 focused on expanding crofelemer access in Europe and specifically for orphan and/or rare diseases. Following the release of the earnings report, JAGX’s price decreased to $ 1. 15. 70M. Markets data provided by S&P and by Xignite See the latest Jaguar Health Inc stock price (JAGX:XNAS), related news, valuation, JAGX is trading within a range we consider fairly valued. Get insights into market trends and stock performance. 7 millones) y del 11% respecto al Q3 2023 ($2. : Forcasts, revenue, earnings, analysts expectations, ratios for Jaguar Health, Inc. Trending News . Insiders Ownership 11. stock price history, forecast, predictions, news and dividends - Jaguar Health Inc. 52380952380952 share position following the split. 16M. EPS and Revenue estimates are for the next 12 months. 6 million. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration. 75. 34 million, a 53. Il Dr. At present, there is no AI or machine-learning-based price prediction available for Jaguar Health (JAGX) stock. 07% of all US stocks. Breast cancer patients accounted for nearly 180 of the 287 participants in this prophylactic clinical trial. #jagx #jagxst Jaguar Health announces 1-for-60 reverse stock split SA News Fri, May 17, 2024 1 Comment Jaguar Health GAAP EPS of -$0. 06 to a high of $6. JAGX will receive pre-clinical support from the National Institute of Allergy and Infectious Diseases. 31%. Setup. 98%. JAGX stock quote prices, financial information, real-time forecasts, and company news from CNN. 1 day ago - Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Accesswire 3 days ago - Jaguar Health Presenting January 13 at Lytham 2025 Investor Healthcare Summit & January 14 at Biotech Showcase - Accesswire 4 days ago - Magdalena Biosciences, a Joint Venture Between Jaguar Health and Get Jaguar Health Inc (JAGX. No, JAGX has not paid a dividend within the past 12 months. Screener. 06, and the Napo Therapeutics, a Jaguar Health family company, has been named 'Best Pharmaceuticals Innovator of the Year - Europe' by The European business publication. 40% of Jaguar Health's shares are currently sold short View Jaguar Health, Inc. 50D Avg. The model utilizes a robust approach combining historical stock data, macroeconomic indicators, and company-specific information. Filings . The event will highlight five ongoing clinical efforts for rare disease indications: three proof-of-concept investigator-initiated trials and two Phase 2 studies We've gathered analysts' opinions on Jaguar Health, Inc. JAGX stock has leapt back from under a dollar per share to its current level. This represents an increase of 597. 51. 30 USD. A reverse stock split consolidates the number of existing shares into fewer, proportionally more valuable, shares. JAGX stock forecast, quote, news & analysis. A stock’s price target is the price at which analysts consider it fairly Only one analyst offered a short-term price target of $6. According to analysts, JAGX price target is 6. 80 for the next financial year. stock price chart and keep track of the current situation with Jaguar family company Napo Therapeutics is an Italian corporation Jaguar established in Milan, Italy in 2021 focused on expanding crofelemer access in Europe and specifically for orphan and/or rare diseases. However, the company's net loss of $9. The company is advancing crofelemer, a novel oral plant-based prescription drug, for rare diseases in Europe. $1. Explore JAGX – Jaguar Health Inc's stock split history and its potential for future splits, Overview News Price History Financials Why JAGX Down? Discussions Forecast Stock Split. JAGX are on downside and on upside. 55M, a decrease of -87. Jaguar family company Napo Therapeutics is an Italian corporation Jaguar established in Milan, Italy in 2021 focused on expanding crofelemer access in Europe and specifically for orphan and/or rare diseases. ($110,462,484). Includes open, high, low, close and volume. That is a compound annual growth rate of -20. View JAGX fundamental and sentiment analysis powered by MarketGrader. In 2021 Jaguar Healths revenue was 434 million a decrease of -5381 compared to the previous years 939 million. JAGX Stock Data Market Cap 11. Get the latest Jaguar Health Inc (JAGX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Industry Biotechnology. Jaguar Health - JAGX Stock Price Target and Predictions. 035 on Nov 14, 2024, recording a -4. 96%. Jaguar Health is one of those companies that have joined in with the SPAC craze as well as boasting plant based prescription medicine. Forecasted Market-Excess Returns. 6% increase in Mytesi prescription volume in Q3 2021, with net sales around $0. $0. However, Jaguar Health is getting a boost from investors once again today. JAGX's third split took place on September 08, 2021. 86 million for 2021. Jaguar Health, Inc. Not long after the market caught wind of Jaguar Health’s value proposition, the JAGX stock price shot higher. 00 and a low forecast of $10,000,000. 1 millones, lo que representa un aumento del 14% en comparación con el Q2 2024 ($2. Get AI intraday signals. Login. JAGX's second split took place on June 07, 2019. 13M. Float 11. Float 9. 64%. 23%. 51% increase from 2019. JAGX Stock Data Market Cap 9. 0821 on Nov 12, 2024 a day before the last earnings report was released. Jan 3 closing price. 67%) After-hours: Jan Predicting JAGX Stock Performance in 2025: A Critical Analysis A stock forecast for JAGX in 2025 attempts to predict the future price movement of the company's stock. 00 USD with a max estimate of 6. 09, FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027 FY 2028 FY 2029 ; Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 For Jaguar Health stock forecast 2031, 12 predictions are offered for each month of 2031 with average Jaguar Health stock forecast of $0. Jaguar Health 's market cap is calculated by multiplying JAGX's current stock price of $1. 79M. 21M. 67% decrease from the last price of $0. Analyst ratings, forecast, price target, upgrades and downgrades. SPACs have exploded in popularity in 2020 with many investors hopping on board the next hottest trend. El producto principal de la compañía, Mytesi, vio un crecimiento de ingresos Source: Shutterstock However, the ailing company has looked a little healthier at the beginning of 2021. com Staff Jaguar Health (NASDAQ:JAGX) announced that a late-breaking abstract showing significant results for crofelemer in breast cancer patients from the Phase 3 OnTarget trial has been accepted for presentation at the San Antonio Breast Cancer Symposium (SABCS) on December 11, 2024. What is the current price of Jaguar Health, Inc. stock grades by Barron's. Jagex considers Bonds, TH Keys, and RuneCoins to be MTX. Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors. The Company is focused on developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for people and animals with gastrointestinal distress. 851 +0. 0. 35% price change in the 48-hour period. Target and Analyst Ratings; The average price target is $0. A must-have platform for stock market information, offering the best tools and updates to supercharge your trading. Interactive stock price chart for Jaguar Health, Inc. The company is supporting proof-of-concept studies for microvillus inclusion disease Stock price forecast and analyst ratings for Jaguar Health Inc (JAGX) in 2023. 60. March 26, 2024 . Jaguar Health (NASDAQ:JAGX) reportó los resultados financieros del tercer trimestre de 2024 con unos ingresos netos combinados de $3. X. C) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments Ticker Symbol: JAGX: Exchange: NASDAQ: Stock Type: Common Stock: Fiscal Year: January - December: Reporting Currency: USD: CIK Code: 0001585608: CUSIP Number: 47010C607 Receive JAGX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Jaguar Health and its competitors with MarketBeat's FREE daily newsletter. Common Stock (JAGX) annual income statements, balance sheets, financial statements, ratios, and cash flow data at Nasdaq. Log In Sign Up. While these . Jaguar Health 's annual revenue for 2020 was $9. If you're new to stock investing, Top Performing Analysts Stock Screener Stock Forecast Trending Stocks Strong Buy Stocks Highest Earnings Stocks Best Dividend Paying Stocks Statistics Stock Market Sectors Stock Market Industries How to Buy Stocks Online. 200D Avg. On average, analysts forecast that JAGX's EPS will be -$2. Stock Price Forecast . jagx stock forecast 2030 JAGX - Stock evaluation, ranks. stock was issued. Be the first to know when Wall Street analysts revise their JAGX stock forecasts and price targets. DF) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments SAN FRANCISCO, CA / ACCESSWIRE / December 10, 2021 / Jaguar Health, Inc. San Francisco, CA (September 3, 2021): Jaguar Health, Inc. 61M Jaguar Health 's annual revenue for Dec 31, 2022 was $11. Only one Why Jaguar Health Stock Skyrocketed 49% Today. Recent JAGX Stock News This week the company announced the completion of a new preclinical toxicology study designed to support more development of its NP-300 (lechlemer) platform. Stock - Share Price, Short Interest, Forecast; Options . (NASDAQ:JAGX) and its wholly owned subsidiary Napo Pharmaceuticals today announced the third-party presentation of findings from the investigator-initiated HALT-D trial evaluating crofelemer for preventing chemotherapy-induced diarrhea (CID) in HER2-positive breast Jaguar Health’s stock was trading at $ 1. JAGX - Jaguar Health Inc Stock Price Forecast 2025, Health (1 days ago) The Jaguar Health Inc (JAGX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $753. Watchlist Compare. analyst ratings, historical stock prices, earnings estimates & actuals. What is the trend in the Jaguar Health share price? An important predictor of whether a stock price will Since May 13, 2015, Jaguar Health's market cap has decreased from $96. (JAGX) with real-time updates, full price history, technical analysis and more. 69%) At close: Jan 17, 2025, 4:00 PM. robinhood. 12 USD. The highest analyst price To add symbols: Type a symbol or company name. The latest Femasys stock prices, stock quotes, news, and FEMY history to help you invest and trade smarter. Options Chain Options Sentiment Options Flow Gamma Exposure Implied Volatility. rrp igfi xuzxj wgywx yjnrf iuuql gnod xzja fcfc aahe